ES2098948T3 - Procedimientos de ensayo de analogos de acido nucleico. - Google Patents

Procedimientos de ensayo de analogos de acido nucleico.

Info

Publication number
ES2098948T3
ES2098948T3 ES94916331T ES94916331T ES2098948T3 ES 2098948 T3 ES2098948 T3 ES 2098948T3 ES 94916331 T ES94916331 T ES 94916331T ES 94916331 T ES94916331 T ES 94916331T ES 2098948 T3 ES2098948 T3 ES 2098948T3
Authority
ES
Spain
Prior art keywords
nucleic acid
acid analog
amount
test procedures
analog test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916331T
Other languages
English (en)
Inventor
Christopher John Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PNA Diagnostics ApS Denmark
Original Assignee
PNA Diagnostics ApS Denmark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PNA Diagnostics ApS Denmark filed Critical PNA Diagnostics ApS Denmark
Application granted granted Critical
Publication of ES2098948T3 publication Critical patent/ES2098948T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN PROCEDIMIENTO DE ENSAYO PARA CUANTIFICAR LA CANTIDAD DE UNA MUESTRA INICIADORA EN UN PROCEDIMIENTO DE AMPLIFICACION DE ACIDO NUCLEICO TAL COMO PCR QUE INVOLUCRA INTENTAR LA AMPLIFICACION EN LA PRESENCIA DE VARIAS CANTIDADES DE UN ANALOGO DE UN ACIDO NUCLEICO EN SUFICIENTE CANTIDAD PARA INHIBIR DICHO PROCEDIMIENTO DE AMPLIFICACION MEDIANTE LA INTERACCION SELECTIVA CON ESPECIES DE ACIDO NUCLEICO PRESENTES, POR EJEMPLO UN PNA COMO DESCRITO EN WO-02-20703. LA CANTIDAD DE LA MUESTRA ES DADA POR LA CANTIDAD DEL ANALOGO DE ACIDO NUCLEICO QUE ES CRITICO PARA CAUSAR EL FALLO DE DICHO PROCEDIMIENTO DE AMPLIFICACION.
ES94916331T 1993-06-02 1994-05-31 Procedimientos de ensayo de analogos de acido nucleico. Expired - Lifetime ES2098948T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311386A GB9311386D0 (en) 1993-06-02 1993-06-02 Nucleic acid analogue assay procedures

Publications (1)

Publication Number Publication Date
ES2098948T3 true ES2098948T3 (es) 1997-05-01

Family

ID=10736511

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916331T Expired - Lifetime ES2098948T3 (es) 1993-06-02 1994-05-31 Procedimientos de ensayo de analogos de acido nucleico.

Country Status (9)

Country Link
US (1) US5912145A (es)
EP (1) EP0701627B1 (es)
JP (1) JP2842694B2 (es)
AU (1) AU6802994A (es)
DE (1) DE69401661T2 (es)
DK (1) DK0701627T3 (es)
ES (1) ES2098948T3 (es)
GB (1) GB9311386D0 (es)
WO (1) WO1994028171A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629178A (en) * 1994-10-28 1997-05-13 Genetics & Ivf Institute Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)
CA2219891C (en) 1995-05-05 2002-01-29 Applied Biosystems, Llc Methods and reagents for combined pcr amplification and hybridization probing assay
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
US6613517B2 (en) * 2000-01-15 2003-09-02 Genelabs Technologies, Inc. Nucleic acid binding assay and selection method
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP1478656B1 (en) 2002-02-01 2009-09-16 Life Technologies Corporation Oligonucleotide compositions with enhanced efficiency
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US20030211483A1 (en) * 2002-05-09 2003-11-13 Schroeder Benjamin G. Methods for the enrichment of low-abundance polynucleotides
WO2004014314A2 (en) 2002-08-12 2004-02-19 David Kirn Methods and compositions concerning poxviruses and cancer
CN104644627A (zh) 2004-09-14 2015-05-27 科罗拉多大学董事会 基于基因靶向使用布新洛尔的治疗方法
US7794659B2 (en) 2005-03-10 2010-09-14 Gen-Probe Incorporated Signal measuring system having a movable signal measuring device
EP1933857A2 (en) * 2005-09-07 2008-06-25 Jennerex Biotherapeutics ULC Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
ES2345954T3 (es) 2006-05-12 2010-10-06 Cepheid Deteccion de la union de recombinacion de adn.
WO2009016433A2 (en) 2006-09-15 2009-02-05 Ottawa Health Research Institute Oncolytic rhabdovirus
US20100129902A1 (en) 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
JP5785942B2 (ja) 2009-06-29 2015-09-30 ルミネックス コーポレーション ヘアピンコンフォメーションを有するキメラプライマーおよびその使用法
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
KR101838472B1 (ko) 2009-09-14 2018-03-15 신라젠(주) 종양 용해 백시니아 바이러스 병용 암 치료요법
WO2011070440A2 (en) 2009-12-10 2011-06-16 Ottawa Hospital Research Institute Oncolytic rhabdovirus
ES2587191T3 (es) 2009-12-23 2016-10-21 Arca Biopharma, Inc. Métodos y composiciones para enfermedades y afecciones cardiovasculares
US9919047B2 (en) 2011-01-04 2018-03-20 Sillajen, Inc. Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
EP2683835B1 (en) 2011-03-08 2017-01-11 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
EP2718427B1 (en) 2011-06-08 2017-01-11 Children's Hospital of Eastern Ontario Research Institute Inc. Compositions for glioblastoma treatment
WO2013036799A2 (en) 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2019107976A (ru) 2013-02-21 2019-08-23 Тёрнстоун Лимитед Партнершип Композиция вакцины
EP3052193B1 (en) 2013-10-03 2018-01-31 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
MA39171A1 (fr) 2014-01-10 2017-07-31 Glaxosmithkline Intellectual Property (No 2) Ltd Dérivés d'hydroxy formamide et leur utilisation
GB201411567D0 (en) * 2014-06-30 2014-08-13 Epistem Ltd Quantification methods
US20180057839A1 (en) 2014-11-26 2018-03-01 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
EP3574114B1 (en) 2017-01-26 2022-06-29 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
US12140592B2 (en) 2017-06-16 2024-11-12 Oklahoma Medical Research Foundation Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
EP3867645B1 (en) 2018-10-18 2024-06-05 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
US12510539B2 (en) 2018-10-18 2025-12-30 Progentec Diagnostics, Inc. Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
CN113614535B (zh) 2018-10-31 2024-08-16 亚利桑那大学评议会 用于辐射诱导的肺损伤的生物标志物和使用方法
EP4031118B1 (en) 2019-09-16 2026-01-28 The Children's Hospital of Philadelphia Mithramycin analog for the treatment of swi-snf mutant tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
GB9016163D0 (en) * 1990-07-24 1990-09-05 Cemu Bioteknik Chemical method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
GB9211979D0 (en) * 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues

Also Published As

Publication number Publication date
JPH08510384A (ja) 1996-11-05
AU6802994A (en) 1994-12-20
DK0701627T3 (da) 1997-07-21
EP0701627A1 (en) 1996-03-20
US5912145A (en) 1999-06-15
WO1994028171A1 (en) 1994-12-08
GB9311386D0 (en) 1993-07-21
DE69401661T2 (de) 1997-06-12
EP0701627B1 (en) 1997-01-29
DE69401661D1 (de) 1997-03-13
JP2842694B2 (ja) 1999-01-06

Similar Documents

Publication Publication Date Title
ES8405072A1 (es) Un procedimiento para la preparacion de un vector de trans- ferencia dna
ES2126626T3 (es) Tecnicas para preparar especimenes para ensayos bacterianos.
BR9805900A (pt) Processo para integrar um fragmento de dna no genoma de uma c-lula de uma planta manocot¡ledonea e composi-Æo para o meio de crescimento de plantas
ES2040199T3 (es) Proceso para controlar la contaminacion de reacciones de amplificacion de acidos nucleicos.
GT197746150A (es) Nuevos agentes antielminticos y proceso para su prepracion
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2069571T3 (es) Proceso de desnitrificacion biologica.
ES8507177A1 (es) Un metodo para detectar bacterias en una muestra a ensayar
ES2084582T3 (es) Utilizacion de un elemento regulador anaerobico en plantas.
ES2058299T3 (es) Metodo de extraer atp.
DE69530001D1 (de) Verbesserungen von oder in bezug auf endometrialfunktion
BR0108212A (pt) Agente e processo para tingimento de fibras de queratina
ES2173194T3 (es) Procedimiento de racemizacion utilizado para la preparacion de levobupivacaina y sus analogos.
ES2090026T3 (es) Dispositivo para intensificar la fluorescencia y cineticas y metodos para utilizar el dispositivo.
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ES2084637T3 (es) Procedimiento para la inactivacion biologica de acidos nucleicos.
ES8701734A1 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES2037032T3 (es) Procedimiento para detectar un analito asi como agente apropiado para ello.
CL2023003739A1 (es) Agentes de protección de plantas a base de enzimas quitinolíticas
ES2056108T3 (es) Empleo de interacciones anticuerpo/antigeno para proteger o modular la actividad biologica.
ES2059311T3 (es) Extraccion de sustancias de ensayo.
ES2062256T3 (es) Procedimiento para producir amida de acido alfa-hidroxiisobutirico.
ES2083840T3 (es) Suspensiones acuosas estables de zeolitas, su procedimiento de obtencion y su utilizacion.
ES2160572T3 (es) Un metodo para el tratamiento de lana.
ES2166773T3 (es) Medio selectivo y procedimiento para la enumeracion de las bacterias propionicas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701627

Country of ref document: ES